Optimizing Alveolar Expansion Prolongs the Effectiveness of Exogenous Surfactant Therapy in the Adult Rabbit
- 1 September 1993
- journal article
- research article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 148 (3) , 569-577
- https://doi.org/10.1164/ajrccm/148.3.569
Abstract
We evaluated four ventilator patterns after the administration of 80 mg/kg bovine lipid extract surfactant (LES) to anesthetized, paralyzed, saline-lavaged New Zealand white rabbits. Two ventilator types were compared: high frequency oscillatory ventilation (HFO) versus conventional mechanical ventilation (CMV), each at high (HI) and low (LO) end-expiratory lung volumes (EELV); n = 6, each group; treatment duration = 4 h. Target PaO2 ranges were > 350 mm Hg for groups with high EELV (i.e., HFO-HI and CMV-HI) and 70 to 100 mm Hg for those with low EELV (i.e., HFO-LO and CMV-LO). Ventilator pressures were limited to < or = 39/9 cm H2O in the CMV-HI group. Five of six CMV-HI-treated animals did not maintain target PaO2 levels. Both ventilator type and strategy influenced outcome significantly. Animals managed with HFO had higher mean arterial pressures (p = 0.004), lower mean airway pressures (Paw) (p < 0.00008) and HCO3- requirements (p < 0.02), larger inflation (p = 0.003) and deflation (p < 0.00001) respiratory system volumes at 10 cm inflation pressure, and higher lung lamellar body (p = 0.0006) and lavage fluid (p = 0.003) phospholipid quantities than did CMV-treated animals. The deflation P-V curve (p = 0.0004), lamellar body (p < 0.00001) and lavage fluid (p = 0.0002) phospholipid levels were superior after the high EELV strategy. We conclude that ventilator pattern strongly influences exogenous surfactant efficacy. Benefits arise from keeping EELV high enough to prevent atelectasis and using small (approximately 2 ml/kg) tidal volumes to prevent overdistension.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 21 references indexed in Scilit:
- Surfactant for the Treatment of Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1987
- High-Frequency Oscillatory Ventilation in Premature Infants with Respiratory FailureAnesthesia & Analgesia, 1987
- Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavageActa Anaesthesiologica Scandinavica, 1986
- Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trialThe Journal of Pediatrics, 1985
- Calcium interactions in pulmonary surfactantBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant.Journal of Clinical Investigation, 1984
- Premature Lambs Rescued from Respiratory Failure with Natural Surfactant: Clinical and Biophysical CorrelatesPediatric Research, 1982
- ARTIFICIAL SURFACTANT THERAPY IN HYALINE-MEMBRANE DISEASEThe Lancet, 1980
- A simplification of the protein assay method of Lowry et al. which is more generally applicableAnalytical Biochemistry, 1977
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959